ChemLex has raised 45 million in new funding. The round was led by Granite Asia. It marks a milestone for the fast-growing AI-for-science startup. The company was founded in 2022. It aims to transform chemical discovery through artificial intelligence and robotics.
ChemLex now operates from its new global headquarters in Singapore. It also unveiled a fully automated, self-driving chemistry laboratory. The facility represents a major shift in drug discovery methods. It replaces slow manual processes with continuous robotic experiments. It creates cleaner data. It also speeds up a historically long development pipeline.
The raise strengthens Singapores role as a centre for advanced science and deep-tech innovation. It also positions ChemLex to compete globally in next-generation pharmaceutical research.
